Abbott (ABT) Reports In-Line Q3 EPS, Misses on Revenue; Offers FY25 EPS Guidance
Go back to Abbott (ABT) Reports In-Line Q3 EPS, Misses on Revenue; Offers FY25 EPS Guidance| Abbott Laboratories (NYSE: ABT) | Delayed: 102.61 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.61 | 52 Week High | $46.38 | |||
| Open | $102.61 | 52 Week Low | $36.00 | |||
| Day High | $102.61 | P/E | 68.41 | |||
| Day Low | $102.61 | EPS | $1.50 | |||
| Volume | 5,107 | |||||
